Contineum Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
CTNM on Nasdaq
Industry
Pharmaceutical Preparations
Location
10578 Science Center Drive, Suite 200, San Diego, California

There are no Buy or Sell transactions made by insiders since 8/15/2023

Contineum Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Carmine N. Stengone CEO and President, Director May 24, 2024
Daniel S. Lorrain Chief Scientific Officer May 24, 2024
Peter Slover Chief Financial Officer May 24, 2024
Stephen L. Huhn CMO & Sr VP, Clinical Dev. Aug 13, 2024
Todd R. Brady Director May 24, 2024
Lori Lyons-Williams Director May 24, 2024
Evert Schimmelpennink Director May 24, 2024
Olivia C. Ware Director May 24, 2024
Versant Venture Capital VI, L.P. 10%+ Owner Apr 9, 2024
Troy A. Ignelzi Director May 24, 2024
Johnson & Johnson 10%+ Owner Apr 9, 2024
John Stephen Healy General Counsel and Corp Sec Jun 3, 2024
Sarah Boyce Director Jun 24, 2024

Recent Insider Transactions by Companies or Individuals for Contineum Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership